Immutep Announces Positive Interim Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer
Immutep S.A. announced today interim results from its ongoing Phase I/II chemoimmunotherapy clinical trial in metastatic breast carcinoma. ImmuFact IMP321 was administered the day after weekly paclitaxel for six months. The interim results show a clinical response rate of 50 per cent compared to 25 per cent with paclitaxel alone. In addition, a robust immune response was observed in clinically-responding patients.Original post by Allergy News From Medical News Today
No commentsStudy Links Obesity To Elevated Risk Of Ovarian Cancer
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. Published in the February 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the research indicates that obesity may contribute to the development of ovarian cancer through a hormonal mechanism.Original post by Allergy News From Medical News Today
No commentsGetting A Good Deal On Gym Membership
New Year is the time when many people decide to join a gym, or revisit a neglected gym membership, and in the current economic climate, gym owners will be concerned not only to attract new members but also to hold onto their existing ones, so now is a good time to get a good deal on your gym membership. According to some of the media reports from the US, gym companies are “slashing prices” (LA Times, 5 Jan 09).Original post by aiming for grace
No commentsEarlier, Individualized Treatment Of Thyroid Cancer Enabled By Molecular Imaging
In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.Original post by Allergy News From Medical News Today
No commentsNovel Glioblastoma Mouse Model Developed By Salk Researchers
Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma - the most common and deadly brain cancer in humans - that closely resembles the development and progression of human brain tumors that arise naturally. “Mouse models of human cancer have taught us a great deal about the basic principles of cancer biology,” says Inder Verma, Ph.D., a professor in the Laboratory of Genetics.Original post by Allergy News From Medical News Today
No commentsDiscovery Could Improve Understanding Of Ulcerative Colitis, Lead To New Therapies
An international team led by University of Pittsburgh School of Medicine researchers has identified genetic markers associated with risk for ulcerative colitis. The findings, which appear as an advance online publication of the journal Nature Genetics, bring researchers closer to understanding the biological pathways involved in the disease and may lead to the development of new treatments that specifically target them.Original post by aiming for grace
No commentsTransplant Program At UT Southwestern University Hospital Recognized For Increasing Organ Donor Rates
The surgical transplant team at UT Southwestern University Hospital has garnered twin awards for its successful efforts to increase organ donation rates. “Each organ donation is an opportunity for new life, so we are gratified with these recognitions,” said Dr. Juan Arenas, chief of surgical transplantation and surgical director for the liver transplant program.Original post by aiming for grace
No commentsFactors Other Than Central Sleep Apnea May Contribute To Poor Sleep Quality In Heart-Failure Patients
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.Original post by aiming for grace
No commentsThe High Societal, Economic Burden Of Insomnia Shown By Study
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment. The study estimates that the total annual cost of insomnia in the province of Quebec is 6.5 billion Canadian dollars, representing about one percent of the province’s $228.5 billion in gross domestic product for 2002.Original post by aiming for grace
No commentsPennsylvania Department Of Health Encourages Smokers To Put Quitting At Top Of Resolution List
Department of Health Acting Secretary Everette James today urged Pennsylvania smokers to make quitting smoking their top New Year’s resolution for 2009. “The start of a new year presents an opportunity to make positive changes in our lives,” said James. “While quitting smoking is rarely easy, having a plan and seeking support can greatly increase your chances of succeeding.Original post by aiming for grace
No comments